These products include: Embosphere?? Microspheres and EmboGold?? Microspheres, which are marketed for symptomatic uterine fibroids, hypervascularized tumors, and arteriovenous malformations in the United States, the European Union, and several other markets outside the United States; HepaSphere??? Microspheres, which are marketed in the European Union, Brazil, and Russia and other emerging markets